BPS Bioscience

As a leading partner for Drug Discovery, BPS Bioscience is synonym to excellence in protein design, expression, purification, and characterization, cell line and lentivirus engineering, and biochemical and cellular assay development. Starting out as a protein company, they have expanded their catalog to now include over 5000 highly specialized products – a powerful tool for pre-clinical drug development researchers from many fields, including epigenetics, cell signaling, SARS-CoV-2, immunotherapy, adoptive cell therapies, and many more.

BPS Biosciences portfolio encompasses not only a large collection of high quality, low aggregation bioactive enzymes and protein complexes, but also encompasses many specialized assay kits (luciferase reporter assays, cell based assays, AlphaLISA, etc.), cell lines and primary cells, small molecules (inhibitors & activators) as well as viral tools (lentiviruses, AAV, VSV).

Science never stands still and neither does BPS Bioscience, bringing out new products almost every week to help guide researchers through the early stages of drug discovery.